Factors associated with changing efficacy of emamectin benzoate against infestations of Lepeophtheirus salmonison Scottish salmon farms by Lees, F. et al.
Strathprints Institutional Repository
Lees, F. and Baillie, M. and Gettinby, G. and Revie, C.W. (2008) Factors associated with changing
efficacy of emamectin benzoate against infestations of Lepeophtheirus salmonis on Scottish salmon
farms. Journal of Fish Diseases, 31 (12). pp. 947-951. ISSN 0140-7775
Strathprints is designed to allow users to access the research output of the University of Strathclyde.
Copyright c© and Moral Rights for the papers on this site are retained by the individual authors
and/or other copyright owners. You may not engage in further distribution of the material for any
profitmaking activities or any commercial gain. You may freely distribute both the url (http://
strathprints.strath.ac.uk/) and the content of this paper for research or study, educational, or
not-for-profit purposes without prior permission or charge.
Any correspondence concerning this service should be sent to Strathprints administrator:
mailto:strathprints@strath.ac.uk
http://strathprints.strath.ac.uk/
Factors associated with changing efficacy of emamectin
benzoate against infestations of Lepeophtheirus salmonis
on Scottish salmon farms
F Lees1,2, M Baillie2, G Gettinby1 and C W Revie2
1 Department of Statistics and Modelling Science, University of Strathclyde, Glasgow, UK
2 Department of Computer and Information Sciences, University of Strathclyde, Glasgow, UK
Keywords: efficacy, emamectin benzoate, Lepeopht-
heirus salmonis, Salmo salar L., Scotland.
The availability and use of medicines to control
infestations of sea lice on Atlantic salmon, Salmo
salar L., farms in Scotland has changed considerably
in the last decade (Lees, Gettinby & Revie 2008b).
Whereas hydrogen peroxide and organophosphate
compounds were used widely throughout the 1990s
and in the early 2000s, only two therapeutants have
remained in common use since 2005: topical
cypermethrin (Excis; Novartis Animal Health,
Camberley, UK) and an oral formulation of
emamectin benzoate (SLICE; Schering Plough
Animal Health, Uxbridge, UK).
Although Excis and SLICE are effective
against the two major species of sea lice that
parasitize Atlantic salmon on Scottish farms, i.e.
Lepeophtheirus salmonis (Krøyer, 1837) and Caligus
elongatus (Nordmann, 1832), reliance on such a
limited range of therapeutants has raised concerns
that resistance in lice will become an increasing
problem unless new medicines become available
and/or existing treatments are carefully managed
(Denholm, Devine, Horsberg, Sevatdal, Fallang,
Nolan & Powell 2002). These concerns are felt not
only in Scotland, but also in other salmon produc
ing countries where the choice of sea lice therapeu
tants is limited (Westcott, Hammell & Burka
2004). Indeed, in recent years, there have been
anecdotal reports of reduced sensitivity of sea lice to
emamectin benzoate, particularly amongst Caligus
rogercresseyi Boxshall & Bravo, 2000, populations in
Chile (S. Bravo, personal communication).
Since gaining UK Marketing Authorization in
2000 the use of SLICE has risen dramatically
on Scottish salmon farms not least because, as an
in feed medicine, it offers several advantages in
terms of application over topical treatments.
However, the key benefit of SLICE is that it
can provide sustained periods of louse clearance
(Stone, Sutherland, Sommerville, Richards &
Endris 2000; Stone, Sutherland, Sommerville,
Richards & Varma 2000; Treasurer, Wallace &
Dear 2002). Two contemporary studies carried
out in Maine (Gustafson, Ellis, Robinson, Mare
nghi & Endris 2006) and in British Columbia
(Saksida, Constantine, Karreman & Donald
2007) provided a snapshot of SLICE treatment
efficacy against infestations of L. salmonis in their
respective regions. While these studies showed
that, overall, SLICE continues to provide
lengthy periods of louse clearance in North
America, neither report attempted to demonstrate
whether efficacy had changed in the period since
regular application of the medicine began.
A recent study examining the efficacy of SLICE
treatments against infestations of mobile L. salmonis
on Scottish farms, in the period 2002 2006 (Lees,
Baillie, Gettinby & Revie 2008a), showed that not
all treatment interventions were equally effective.
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Specifically, there appeared to be evidence of
variation between geographical regions and a
reduction in efficacy over time. This short commu
nication builds on the previous study (Lees et al.
2008a) by further examining the apparent reduc
tion in treatment efficacy.
Sea lice abundance, treatment and site stocking
data were drawn from 56 Atlantic salmon farms
located along the West coast of Scotland between
2002 and 2006. Sites on the Scottish mainland
were divided above and below 57N and are
referred to as North and South. Sites referred
to as Western Isles include those on the East
coast of South Uist and the East & West coasts
of Harris and Lewis. All farms were owned and
managed by Marine Harvest (Scotland). Site wide
treatment episodes, where SLICE was the only
sea lice medicine administered and where all pens
began treatment on the same day were analysed
(n = 185). As described in the previous study
(Lees et al. 2008a), these treatment episodes were
screened to establish whether sufficient lice count
data were available in the weeks prior to and
following treatment to allow further analysis
(n = 108). In addition, 26 treatments that were
administered before guideline treatment trigger
levels had been reached (i.e. mean abundance of
L. salmonis adult females < 0.5 February June,
or ‡ 1.0 between July and January) were screened
out. This resulted in a final data set of 82
treatment episodes administered across 40 farms.
Using the available lice count data, post treat
ment L. salmonis abundance in the 12 weeks
(83 days) following treatment intervention was
examined as mean mobile lice per fish; and as a
percentage of pretreatment abundance based on
matched pre and post treatment lice counts (mean
post treatment abundance/mean pretreatment
abundance · 100). Treatments were then classified
as effective (n = 63) or ineffective (n = 19), with
effective treatments defined as those where the
mean abundance of mobile L. salmonis fell below
40% of pretreatment levels in at least one of the
12 weeks following treatment. A summary of all
treatments included in the analysis is presented in
Table 1.
In the previous study (Lees et al. 2008a), all
treatment episodes were analysed regardless of
whether they were classified as effective or not.
However, as treatment episodes may be ineffective
for a number of reasons unrelated to reduced
sensitivity or resistance amongst lice populations,
it was important to further examine underlying
trends amongst only those treatment episodes
deemed to be effective (n = 63). Figure 1a shows
that, despite very different pretreatment lice
burdens ranging from 18 lice per fish in 2003
to five in 2005, mean mobile abundance fell
below 3.5 within 27 days of treatment initiation
in all years. Mean abundance continued to fall to
below 1.3 lice by day 55.
The efficacy profiles (Fig. 1b) show that in 2002
and 2003 mean louse abundance fell to 10% of
pretreatment levels within 20 days of treatment
intervention and below 3% by day 27. Treatments
applied in 2004 were also highly effective, with
mean abundance falling to 6% of pretreatment
levels by day 27. In 2005, lice levels fell to 23% of
pretreatment abundance within 27 days, continued
to fall to 15% by day 55, recovering gradually
thereafter. In 2006, abundance as a proportion of
pretreatment levels fell to 19% by day 27 and to 9%
between days 28 and 34, however after this point it
began to rise.
A general linear model was developed for the 63
effective treatment episodes. In addition to year of
treatment, the model examined the effect of several
other factors on post treatment mobile L. salmonis
abundance and included pretreatment lice loads as a
co variate (Table 2). To improve normality and
equalize variances, data were logarithmically trans
formed [ln(x + 1)] prior to analysis. Least squares
means and their 95% confidence intervals (CI) are
reported untransformed.
All factors were found to be significant and a
significant interaction between region and days after
treatment was observed (Table 2 & Fig. 2). Post
treatment abundance in 2005 was significantly
higher than in 2002 and 2003, while in 2006
levels were significantly higher than in all previous
years. Treatments administered in the autumn and
winter months resulted in significantly higher post
treatment lice levels compared with those applied in
the spring and summer. Treatments administered
on farms in the South region performed signifi
Table 1 Numbers of effective and ineffective SLICE treatment
episodes on 40 Atlantic salmon farms in Scotland in the years
2002–2006
2002 2003 2004 2005 2006 Total
Effective episodes 9 15 20 15 4 63
Ineffective episodes 0 2 4 5 8 19
Total 9 17 24 20 12 82
cantly less well than those in the North region and
the Western Isles.
To examine the upward trend in ineffective
treatment episodes between 2002 and 2006
(Table 1), a logistic regression model was developed
to determine whether any factors were associated
with ineffective treatment episodes (Table 3). All
treatments given in 2002 were effective, therefore
episodes administered in this year could not be
included in the logistic model, leaving a total of 19
ineffective and 54 effective treatment episodes for
analysis.
Table 3 shows the final logistic regression model
that was developed and includes the factors that
were found to be significant within the multivar
iable analysis (P £ 0.05). The analysis shows that
treatments given in 2006 were 11 times (P = 0.02,
CI 1.42 90.17) more likely to be ineffective than
those given in 2003 and that winter treatments were
also around 11 times (P = 0.01, CI 1.60 71.73)
more likely to fail than those given in the spring.
Pretreatment mobile lice abundance was included
in the model as a forced co variate, however it was
not found to be significant, indicating that lice
levels prior to treatment intervention were not a
factor in determining the success of a treatment. In
addition, it was found that production year,
geographical region, and whether the treatment
was part of a loch wide intervention had no
significant association with ineffective treatment
episodes. Sensitivity analysis was carried out to
assess the impact of revising the effective treatment
episode criteria up or down from 40% of pretreat
ment levels. Two additional logistic regression
analyses were performed. In the first analysis, the
cut off point for effective treatment episodes was
lowered to 20% of pretreatment lice levels; in the
second, the cut off point was increased to 50%. In
both analyses, year (2006) and season (winter) were
once again found to be the only statistically
significant factors.
It is acknowledged that the efficacy of in feed sea
lice treatment episodes may be influenced by a
number of factors relating to fish appetite, sub
therapeutic dosing and concurrent disease. Further
more, it should be noted that the apparent
reduction in treatment efficacy reported herein
occurred within a 5 year period when lice
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Figure 1 (a) Mean mobile Lepeophtheirus
salmonis abundance, pretreatment and
0–83 days after commencement of treat-
ment. (b) Post-treatment mobile L. salmonis
abundance as a percentage of pretreatment
abundance, 7–83 days after commencement
of treatment. Plots based on data from 63
effective treatment episodes at 36 Atlantic
salmon farms in Scotland in the period 2002–
2006.
abundance was found to be comparatively low (Lees
et al. 2008b). Nevertheless, it is critical that the
efficacy of this widely used sea lice medicine
continues to be monitored closely and that fish
health managers remain vigilant in reporting any
apparent treatment failures.
Table 2 Results of the general linear
model analysis of Lepeophtheirus salmonis
abundance following SLICE treatment.
Results based on data from 63 effective
treatment episodes at 36 Atlantic salmon
farms in Scotland in the period 2002–2006Factor P Level
Post treatment
mobile abundance
% of
treatments
(n = 63)
Least
squares
mean 95% CI
aPretreatment
mobile
abundance
0.00
bDays after
treatment
0.00 7 13 2.08 1.63 2.62 65
14 20 1.21 0.89 1.60 65
21 27 0.61 0.38 0.88 71
28 34 0.69 0.44 0.99 63
35 41 0.75 0.49 1.05 68
42 48 0.73 0.46 1.04 62
49 55 0.69 0.44 0.97 68
56 62 0.90 0.61 1.23 62
63 69 0.99 0.67 1.36 57
70 76 0.99 0.67 1.37 54
77 83 1.04 0.71 1.43 54
Region 0.00 North 0.73 0.54 0.95 32
South 1.43 1.18 1.70 33
Western Isles 0.73 0.57 0.91 35
Year 0.00 2002 0.46 0.26 0.68 14
2003 0.57 0.40 0.76 24
2004 0.81 0.64 0.99 32
2005 1.05 0.85 1.29 24
2006 2.22 1.59 3.01 6
Production year 0.00 First 0.72 0.58 0.88 43
Second 1.18 0.96 1.42 57
Season 0.00 Spring
(Feb Apr)
0.57 0.41 0.75 35
Summer (May Jul) 0.60 0.44 0.77 27
Autumn
(Aug Oct)
1.13 0.92 1.37 29
Winter
(Nov Jan)
1.64 1.17 2.21 10
Loch wide 0.00 No 0.77 0.62 0.92 62
Yes 1.13 0.94 1.33 38
Region · days
after treatment
0.04 See Fig. 2
aForced co-variate with coefficient of 0.20 (95% CI 0.13–0.28).
b% of treatments for the variable Days after treatment refers to the percentage of treated farms that
were monitored for sea lice in each 7-day time period following treatment.
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Figure 2 Profile plot showing the signifi-
cant (P < 0.05) interaction between region
and days after treatment. Post-treatment
mobile abundances based on data from 63
effective treatment episodes at 36 Atlantic
salmon farms in Scotland in the period
2002–2006.
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